<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ADTX
Aditxt
$
()


  • Aditxt provides update on plans for 2024 year-end, accessing strategic capital

    10/3/2024 - 08:28am
  • ADiTx Therapeutics trading halted, news pending

    10/1/2024 - 19:50pm
  • Aditxt announces 1-for-40 reverse stock split

    9/27/2024 - 08:22am
  • Evofem Biosciences files proxy for stockholder approval of acquisition by Aditxt

    9/24/2024 - 08:44am
  • Aditxt, Evofem enter second amendment to plan of merger

    9/9/2024 - 08:21am
  • Aditxt files to sell $150M of common stock for holders

    9/6/2024 - 17:07pm
  • Aditxt sells 1.13M shares at $1.06 in registered direct offering

    8/9/2024 - 08:20am
  • Evofem signs Phexxi license agreement for Middle East with UAE's Pharma 1

    7/23/2024 - 08:50am
  • Aditxt and Evofem restate merger agreement towards September 30 closing

    7/17/2024 - 06:33am
  • Aditxt files $100M mixed securities shelf

    7/11/2024 - 16:32pm
  • Aditxt in pact to acquire Appili Therapeutics for 5.6c per share

    4/2/2024 - 08:39am
  • Appili Therapeutics signs definitive agreement to be acquired by Aditxt

    4/2/2024 - 07:50am
  • Aditxt files to sell 3.785M shares of common stock for holders

    1/18/2024 - 16:33pm
  • ADiTx Therapeutics trading resumes

    1/8/2024 - 09:00am
  • ADiTx Therapeutics trading halted, news pending

    1/8/2024 - 08:25am
dynamic_feed Breaking News